论文部分内容阅读
随着中国加入 WTO 的进程临近,药材市场趋于火爆。由于去年某些主产地受灾减产,上市量不足,某些药材品种呈现供不应求的态势,价格上扬。笔者经大量调查了解,为广大药农提供以下品种,仅供参考。穿心莲全草入药,具有消炎止痛的功效,生长周期1年,用种子繁殖,在早春育苗,立夏前移栽,也可在早稻收获后移栽。产量高,亩产干货800～1000千克,亩产值2400～3000元。辛夷花又名迎春花,以花蕾入药,市价一直平
With the process of China’s accession to the WTO approaching, the medicinal herbs market tends to be hot. As a result of some major producing areas of last year, the yield reduction, lack of listing, some varieties of herbs showed the situation in short supply, the price rise. The author after a lot of investigation to understand, for the majority of drug farmers to provide the following varieties, for reference purposes only. Andrographis paniculata herbs, with the effect of anti-inflammatory analgesic, the growth cycle of 1 year, with seed breeding, nursery in early spring, before the summer transplanting, but also in the early rice after transplanting. High output, dry output per acre 800 ~ 1000 kg, 2400 ~ 3000 yuan per mu. Magnolia flower, also known as spring flowers, flower buds medicine, the market price has been flat